Results 11 to 20 of about 2,453,026 (292)
FACTOR V LEIDEN AND THROMBOEMBOLISM [PDF]
Basrah Journal of Surgery, 2004 Zuhair Al-Barazanchi
doaj +2 more sources
Standardization of Coagulation Factor V Reference Intervals, Prothrombin Time, and Activated Partial Thromboplastin Time in Mice for Use in Factor V Deficiency Pathological Models [PDF]
, 2022 Author Contributions JADPM contributed to the design of the experiments and participated in the collection, analysis, and interpretation of the data. He also contributed to drafting the manuscript and preparing the figures and tables.
De Pablo Moreno, Juan Andrés +2 more
core +1 more source
The prevalence of Factor V Leiden (Arg506Gln) mutation in King Khalid University Hospital patients, 2017–2019 [PDF]
, 2021 Arg506Gln mutation is responsible for one of the procoagulant factors and most common inherited thrombophilia in the Factor V Leiden (FVL) family. The replacement of the missense mutation for Arg506Gln / R506Q is at 1691st position from Guanine to ...
Alotaibi, Abdulaziz A. +10 more
core +1 more source
Frontiers in Pediatrics, 2022 We summarized two cases of congenital factor V deficiency (FVD) associated with a novel F5 mutation, and analyzed the relationship of the clinical features and genetic characteristics in congenital FVD.
Lin Cheng, Ying Li, Wenjuan Zhou, Tao Bo
doaj +1 more source
A Case of Acquired Factor V Deficiency in Patient with Bleeding
TH Open, 2020 Low frequency of rare diseases origins from missed diagnosis addressing to poor prognosis. Acquired factor V inhibitor is a very low frequent bleeding condition (prevalence: 0.09/100,000,000–0.29/1,000,000 per year).
Davide Vetri +6 more
doaj +1 more source
Frontiers in Medicine, 2022 BackgroundFactor V (FV) deficiency is a rare disease, with a low incidence rate in Asia. Therefore, the F5 mutation in the Taiwanese population is poorly understood.MethodsA Chinese family with FV deficiency was included, and the patient and his family ...
Yueh-Shih Chang +8 more
doaj +1 more source
Coagulation factor V is a marker of tumor-infiltrating immune cells in breast cancer
OncoImmunology, 2020 Background Factor (F) V is an essential cofactor in blood coagulation, however, F5 expression in breast tumors has also been linked to tumor aggressiveness and overall survival. The specific role of FV in breast cancer is yet unknown.
Mari Tinholt +8 more
doaj +1 more source
Reflections on different labels for Factor V [PDF]
, 1994 Ostendorf F, Angleitner A. Reflections on different labels for Factor V. European Journal of Personality. 1994;8(4):341-349.Discrepancies among different versions of Factor V may be largely explained by differences in the personality definitions and the ...
Angleitner, Alois +1 more
core +2 more sources
Prevalence of and Risk Factors for Hepatitis C Virus Infection in World Trade Center Responders [PDF]
, 2023 The risk of hepatitis C virus (HCV) infection among emergency responders exposed to human remains, blood/bodily fluids, and/or sewage is unknown. Methods: A cross-sectional study of 3871 World Trade Center General Responder Cohort (WTCGRC) members ...
Dieterich D. T. +4 more
core +1 more source
Comparison between thrombophilic gene polymorphisms among high risk patients
Romanian Journal of Internal Medicine, 2020 Introduction. The purpose of this study was to compare the role of the thrombophilic variants among two groups of high risk patients with vascular disorders and recurrent pregnancy loss.
Levkova Mariya +4 more
doaj +1 more source